Skip to main content
  • < Back
  • Lisbon Addictions 2022 logo
  • About
    • About the conference
    • App
    • Organisers & Partners
    • Latest updates
    • Press room
    • Registration
    • Venue 22
      • About the venue
      • Rooms
    • Call for abstracts
  • Programme 22
  • Tracks 22
  • Speakers 22
  • Side events 22
  • Subscribe
days hours minutes seconds
Previous sessionNext session

Hepatitis C testing and treatment

Knowledge market 3 (K3)
In programme
Thursday, 24 November, 2022 - 13:20 to 14:50
View presentations

About

This session brings together a variety of studies focused on testing and treatment for hepatitis C infection.

Chair

Bruneau
Julie
  • Professor,
  • Université de Montréal,
  • Montreal,
  • Canada
Grebely
Jason
  • Professor,
  • The Kirby Institute,
  • Australia

Type

  • Oral presentation session

Tracks

  • Hepatitis C, other infectious diseases and drug-related harms

Keywords

  • Health consequences
  • Hepatitis
  • Infectious diseases
  • Treatment

Presentations

Thursday, 24 November

13:20
Oral presentation

A novel hepatitis C intervention in Denmark to test and treat people who inject drugs

13:20 to 14:50
Knowledge market 3 (K3)
Jonas Demant
Oral presentation

Declining Prevalence of Current HCV Infection and Increased Treatment Uptake Among People Who Inject Drugs: The ETHOS Engage Study

13:20 to 14:50
Knowledge market 3 (K3)
Anna Conway
Oral presentation

Non-uptake of treatment for hepatitis C in the antiviral era: A qualitative analysis

13:20 to 14:50
Knowledge market 3 (K3)
Suzanne Fraser
Previous sessionView the programmeNext session

Lisbon Addictions, European Conference on Addictive Behaviours and Dependencies.

Quick links

  • Policy & disclaimer
  • Diversity statement
  • Newsletter
  • Programme outline
  • Practical information
  • Twitter
  • Facebook
  • Mail
  • LinkedIn
© 2025 Lisbon Addictions 2022 All rights reserved.